Purification, cDNA cloning and expression of 15-oxoprostaglandin 13-reductase from pig lung

Ensor, C.M.; Zhang, H.; Tai, H.H.; Biochem. J. 330, 103-108 (1998)

show all sequences of 1.3.1.48

Data extracted from this reference:

Cloned(Commentary)
Commentary Organism
expression in Escherichia coli Sus scrofa
KM Value [mM]
KM Value [mM] KM Value Maximum [mM] Substrate Commentary Organism Structure
0.0077
-
15-ketoprostaglandin E1
-
Sus scrofa
0.0083
-
15-ketoprostaglandin E1 recombinant enzyme Sus scrofa
0.01
-
leukotriene B4 recombinant enzyme Sus scrofa
0.015
-
NADPH
-
Sus scrofa
0.016
-
NADPH recombinant enzyme Sus scrofa
0.0182
-
15-Ketoprostaglandin E2 recombinant enzyme Sus scrofa
0.019
-
15-Ketoprostaglandin E2
-
Sus scrofa
0.088 0.094 NADH
-
Bos taurus
0.153
-
NADH
-
Sus scrofa
0.16
-
NADH recombinant enzyme Sus scrofa
Organism
Organism Primary Accession No. (UniProt) Commentary Textmining
Bos taurus
-
-
-
Sus scrofa
-
-
-
Purification (Commentary)
Commentary Organism
native and recombinant enzyme Sus scrofa
Source Tissue
Source Tissue Commentary Organism Textmining
lung
-
Bos taurus
-
lung
-
Sus scrofa
-
Specific Activity [micromol/min/mg]
Specific Activity Minimum [µmol/min/mg] Specific Activity Maximum [µmol/min/mg] Commentary Organism
2.56
-
-
Sus scrofa
2.6
-
recombinant enzyme expressed in Escherichia coli Sus scrofa
Substrates and Products (Substrate)
Substrates Commentary Substrates Literature (Substrates) Organism Products Commentary (Products) Literature (Products) Organism (Products) Reversibility
(5S,12R)-dihydroxy-(6E,8Z,10Z,14E)-eicosatetraenoic acid + NADH trivial name leukotriene B4, enzyme exhibits a 15-ketoprostaglandin-13-reductase and a very low leukotriene B4 12-hydroxydehydrogenase activity 390827 Sus scrofa ?
-
-
-
?
(5Z,13E)-11alpha-hydroxy-9,15-dioxoprost-5,13-dienoate + NAD(P)H
-
390827 Sus scrofa (5Z)-11alpha-hydroxy-9,15-dioxoprost-5-enoate + NAD(P)+
-
390827 Sus scrofa ir
(5Z,13E)-11alpha-hydroxy-9,15-dioxoprost-5,13-dienoate + NAD(P)H
-
390827 Bos taurus (5Z)-11alpha-hydroxy-9,15-dioxoprost-5-enoate + NAD(P)+
-
390827 Bos taurus ir
11-hydroxy-9,15-dioxoprosta-5,13-dien-1-oic acid + NAD(P)H
-
390827 Sus scrofa 11-hydroxy-9,15-dioxoprosta-5-en-1-oic acid + NAD(P)+
-
-
-
?
11-hydroxy-9,15-dioxoprosta-5,13-dien-1-oic acid + NAD(P)H
-
390827 Bos taurus 11-hydroxy-9,15-dioxoprosta-5-en-1-oic acid + NAD(P)+
-
390827 Bos taurus ?
15-ketoprostaglandin E1 + NADPH
-
390827 Sus scrofa ?
-
-
-
-
leukotriene B4 + NADPH
-
390827 Sus scrofa ?
-
-
-
-
Turnover Number [1/s]
Turnover Number Minimum [1/s] Turnover Number Maximum [1/s] Substrate Commentary Organism Structure
0.517
-
15-ketoprostaglandin E1 cofactor NADH Sus scrofa
1.52
-
15-ketoprostaglandin E1 cofactor NADPH Sus scrofa
Cofactor
Cofactor Commentary Organism Structure
NAD(P)H
-
Bos taurus
NAD(P)H 3fold higher activity with NADPH compared to NADH Sus scrofa
Cloned(Commentary) (protein specific)
Commentary Organism
expression in Escherichia coli Sus scrofa
Cofactor (protein specific)
Cofactor Commentary Organism Structure
NAD(P)H
-
Bos taurus
NAD(P)H 3fold higher activity with NADPH compared to NADH Sus scrofa
KM Value [mM] (protein specific)
KM Value [mM] KM Value Maximum [mM] Substrate Commentary Organism Structure
0.0077
-
15-ketoprostaglandin E1
-
Sus scrofa
0.0083
-
15-ketoprostaglandin E1 recombinant enzyme Sus scrofa
0.01
-
leukotriene B4 recombinant enzyme Sus scrofa
0.015
-
NADPH
-
Sus scrofa
0.016
-
NADPH recombinant enzyme Sus scrofa
0.0182
-
15-Ketoprostaglandin E2 recombinant enzyme Sus scrofa
0.019
-
15-Ketoprostaglandin E2
-
Sus scrofa
0.088 0.094 NADH
-
Bos taurus
0.153
-
NADH
-
Sus scrofa
0.16
-
NADH recombinant enzyme Sus scrofa
Purification (Commentary) (protein specific)
Commentary Organism
native and recombinant enzyme Sus scrofa
Source Tissue (protein specific)
Source Tissue Commentary Organism Textmining
lung
-
Bos taurus
-
lung
-
Sus scrofa
-
Specific Activity [micromol/min/mg] (protein specific)
Specific Activity Minimum [µmol/min/mg] Specific Activity Maximum [µmol/min/mg] Commentary Organism
2.56
-
-
Sus scrofa
2.6
-
recombinant enzyme expressed in Escherichia coli Sus scrofa
Substrates and Products (Substrate) (protein specific)
Substrates Commentary Substrates Literature (Substrates) Organism Products Commentary (Products) Literature (Products) Organism (Products) Reversibility
(5S,12R)-dihydroxy-(6E,8Z,10Z,14E)-eicosatetraenoic acid + NADH trivial name leukotriene B4, enzyme exhibits a 15-ketoprostaglandin-13-reductase and a very low leukotriene B4 12-hydroxydehydrogenase activity 390827 Sus scrofa ?
-
-
-
?
(5Z,13E)-11alpha-hydroxy-9,15-dioxoprost-5,13-dienoate + NAD(P)H
-
390827 Sus scrofa (5Z)-11alpha-hydroxy-9,15-dioxoprost-5-enoate + NAD(P)+
-
390827 Sus scrofa ir
(5Z,13E)-11alpha-hydroxy-9,15-dioxoprost-5,13-dienoate + NAD(P)H
-
390827 Bos taurus (5Z)-11alpha-hydroxy-9,15-dioxoprost-5-enoate + NAD(P)+
-
390827 Bos taurus ir
11-hydroxy-9,15-dioxoprosta-5,13-dien-1-oic acid + NAD(P)H
-
390827 Sus scrofa 11-hydroxy-9,15-dioxoprosta-5-en-1-oic acid + NAD(P)+
-
-
-
?
11-hydroxy-9,15-dioxoprosta-5,13-dien-1-oic acid + NAD(P)H
-
390827 Bos taurus 11-hydroxy-9,15-dioxoprosta-5-en-1-oic acid + NAD(P)+
-
390827 Bos taurus ?
15-ketoprostaglandin E1 + NADPH
-
390827 Sus scrofa ?
-
-
-
-
leukotriene B4 + NADPH
-
390827 Sus scrofa ?
-
-
-
-
Turnover Number [1/s] (protein specific)
Turnover Number Minimum [1/s] Turnover Number Maximum [1/s] Substrate Commentary Organism Structure
0.517
-
15-ketoprostaglandin E1 cofactor NADH Sus scrofa
1.52
-
15-ketoprostaglandin E1 cofactor NADPH Sus scrofa


See also following references to EC number 1.3.1.48 (sorted by year of publication):
No.1st authorPub
Med
titleorganimsjournalvolumepagesyearActivating CompoundApplicationCloned(Commentary)Crystallization (Commentary)EngineeringGeneral StabilityInhibitorsKM Value [mM]LocalizationMetals/IonsMolecular Weight [Da]Natural Substrates/ Products (Substrates)Organic Solvent StabilityOrganismOxidation StabilityPosttranslational ModificationPurification (Commentary)ReactionRenatured (Commentary)Source TissueSpecific Activity [micromol/min/mg]Storage StabilitySubstrates and Products (Substrate)SubunitsTemperature Optimum [°C]Temperature Range [°C]Temperature Stability [°C]Turnover Number [1/s]pH OptimumpH RangepH StabilityCofactorKi Value [mM]pI ValueIC50 ValueActivating Compound (protein specific)Application (protein specific)Cloned(Commentary) (protein specific)Cofactor (protein specific)Crystallization (Commentary) (protein specific)Engineering (protein specific)General Stability (protein specific)IC50 Value (protein specific)Inhibitors (protein specific)Ki Value [mM] (protein specific)KM Value [mM] (protein specific)Localization (protein specific)Metals/Ions (protein specific)Molecular Weight [Da] (protein specific)Natural Substrates/ Products (Substrates) (protein specific)Organic Solvent Stability (protein specific)Oxidation Stability (protein specific)Posttranslational Modification (protein specific)Purification (Commentary) (protein specific)Renatured (Commentary) (protein specific)Source Tissue (protein specific)Specific Activity [micromol/min/mg] (protein specific)Storage Stability (protein specific)Substrates and Products (Substrate) (protein specific)Subunits (protein specific)Temperature Optimum [°C] (protein specific)Temperature Range [°C] (protein specific)Temperature Stability [°C] (protein specific)Turnover Number [1/s] (protein specific)pH Optimum (protein specific)pH Range (protein specific)pH Stability (protein specific)pI Value (protein specific)ExpressionGeneral InformationGeneral Information (protein specific)Expression (protein specific)KCat/KM [mM/s]KCat/KM [mM/s] (protein specific)
699958Zhao-Restoration of leukotriene B(4 ...unidentified adenovirusLung Cancer68161-1692010--1--------1-1-----41-1-1---1--1-----11----------1-----41-1-1---1---------
690204ItohLeukotriene B4 12-hydroxydehyd ...Rattus norvegicusXenobiotica38249-2632008--1---691----1--1--1--11--------1-----11----6-91------1-1--11---------------
687562ChouIdentification of a novel pros ...Mus musculusJ. Biol. Chem.28218162-181722007--1----5-----2--1--24-5----5---1-----11------5-------1-24-5----5----------
674369HoriCrystal structure of anti-conf ...Cavia porcellusJ. Biochem.140457-4662006---1--1------1-------------------------1---1------------------------------
656219HoriStructural basis of leukotrien ...Cavia porcellusJ. Biol. Chem.27922615-226232004---1-------1-1--1-----1----------------1---------1---1----1---------------
390829YamamotoImmunohistochemical localizati ...Cavia porcellusEur. J. Biochem.2686105-61132001--1----2-----9--1--1--2--------------1-------2-------1-1--2---------------
390830DickAntioxidative function and sub ...Rattus norvegicusJ. Biol. Chem.27640803-408102001--1----20-----4--1-----20----20---------1-------20-------1----20----20----------
390828ClishOxidoreductases in lipoxin A4 ...Sus scrofaJ. Biol. Chem.27525372-253802000--1----------3-----1--1--------1-----11----------------1--1---------------
390827Ensor-Purification, cDNA cloning and ...Bos taurus, Sus scrofaBiochem. J.330103-1081998--1----10-----2--1--22-7----2---2-----12------10-------1-22-7----2----------
390825Nikaido15-Ketoprostaglandin delta 13- ...Bos taurusCurr. Eye Res.1217-22.1993------4-1-1--1--1--46211-------1------1----4--1-1----1-46211--------------
390826KitamuraPurification of a 15-ketoprost ...Rattus norvegicusBiochem. Mol. Biol. Int.30839-8471993------41--1--1--1--101-221-----1-1------1----4-1--1----1-101-221-----1--------
390820HansenPurification and assay of 15-k ...Bos taurus, Gallus gallus, Homo sapiensMethods Enzymol.86156-1671982------37--26-3--1--31215-1------3------3----3-7--26---1-31215-1-------------
390821JarabakIsolation and properties of a ...Homo sapiensMethods Enzymol.86163-1671982------37-----1--1--1127-1------32-----3----327-------1-1127-1-------------
390823HansenPurification and characterizat ...Bos taurusBiochim. Biophys. Acta574136-1451979------22--1--1--1--1112-1--1---1------1----2-2--1----1-1112-1--1----------
390824Westbrook15-Ketoprostaglandin delta13 r ...Homo sapiensArch. Biochem. Biophys.185429-4421978------57--1--1--1--111811------23-----2----537--1----1-111811-------------
390822WestbrookPurification and partial chara ...Homo sapiensBiochem. Biophys. Res. Commun.66541-5461975-------2-----2--1--21-3-1---11-2------2------2-------1-21-3-1---11--------